These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice. Du B, Li DP, Xu KL, Pan XY. Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128 [Abstract] [Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 20; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
6. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors. Yan CH, Wang JZ, Liu DH, Xu LP, Chen H, Liu KY, Huang XJ. Eur J Haematol; 2013 Oct 20; 91(4):304-14. PubMed ID: 23837640 [Abstract] [Full Text] [Related]
9. A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation. Lutz C, Massenkeil G, Nagy M, Neuburger S, Tamm I, Rosen O, Dörken B, Arnold R. Bone Marrow Transplant; 2008 May 20; 41(9):805-12. PubMed ID: 18195682 [Abstract] [Full Text] [Related]
12. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation. Orti G, Lowdell M, Fielding A, Samuel E, Pang K, Kottaridis P, Morris E, Thomson K, Peggs K, Mackinnon S, Chakraverty R. Transplantation; 2009 Dec 15; 88(11):1312-8. PubMed ID: 19996931 [Abstract] [Full Text] [Related]
14. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia. Sánchez-García J, Serrano J, Gómez P, Martínez F, Martín C, Román-Gómez J, Rodríguez A, Herrera C, García JM, Alvarez MA, Torres A. Haematologica; 2006 Mar 15; 91(3):340-7. PubMed ID: 16531257 [Abstract] [Full Text] [Related]
19. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT. Yan CH, Xu LP, Liu DH, Chen H, Wang Y, Wang JZ, Wang FR, Han W, Liu KY, Huang XJ. Clin Transplant; 2015 Jul 15; 29(7):594-605. PubMed ID: 25969866 [Abstract] [Full Text] [Related]